These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 11401115)

  • 21. Aldosterone escape during ACE inhibitor therapy in chronic heart failure.
    Struthers AD
    Eur Heart J; 1995 Dec; 16 Suppl N():103-6. PubMed ID: 8682054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacogenetics of chronic heart failure--beta blockers].
    Vasků A; Spinarová L; Pávková-Goldbergová M; Spinar J; Soucek M; Vítovec J
    Cas Lek Cesk; 2006; 145(2):148-52; discussion 152-3. PubMed ID: 16521406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease.
    Haas M; Yilmaz N; Schmidt A; Neyer U; Arneitz K; Stummvoll HK; Wallner M; Auinger M; Arias I; Schneider B; Mayer G
    Kidney Blood Press Res; 1998; 21(1):66-9. PubMed ID: 9661139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
    Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
    Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [I/D angiotensin-converting enzyme gene polymorphism: structural changes in the myocardium and predictive value in chronic heart failure].
    Voronkov LH; Horovenko NH; Mazur ID; Liashenko AV
    Lik Sprava; 2012 Dec; (8):36-42. PubMed ID: 23786008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism.
    Bleumink GS; Schut AF; Sturkenboom MC; van Duijn CM; Deckers JW; Hofman A; Kingma JH; Witteman JC; Stricker BH
    Pharmacogenet Genomics; 2005 Feb; 15(2):75-81. PubMed ID: 15861031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism.
    So WY; Ma RC; Ozaki R; Tong PC; Ng MC; Ho CS; Lam CW; Chow CC; Chan WB; Kong AP; Chan JC
    Kidney Int; 2006 Apr; 69(8):1438-43. PubMed ID: 16395257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ACE gene insertion/deletion polymorphism on response to spironolactone in patients with chronic heart failure.
    Cicoira M; Rossi A; Bonapace S; Zanolla L; Perrot A; Francis DP; Golia G; Franceschini L; Osterziel KJ; Zardini P
    Am J Med; 2004 May; 116(10):657-61. PubMed ID: 15121491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibitor and spironolactone combination therapy. New objectives in congestive heart failure treatment.
    Zannad F
    Am J Cardiol; 1993 Jan; 71(3):34A-39A. PubMed ID: 8422003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on survival in hemodialyzed patients.
    Kiss I; Ambrus C; Kulcsár I; Szegedi J; Kerkovits L; Tislér A; Kiss Z;
    Medicine (Baltimore); 2014 Dec; 93(28):e315. PubMed ID: 25526485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure.
    Abraham MR; Olson LJ; Joyner MJ; Turner ST; Beck KC; Johnson BD
    Circulation; 2002 Oct; 106(14):1794-9. PubMed ID: 12356632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment?
    Lim PO; MacFadyen RJ; Struthers AD
    Heart; 2000 Mar; 83(3):257-61. PubMed ID: 10677399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients: a single-center analysis.
    Barocci S; Ginevri F; Valente U; Torre F; Gusmano R; Nocera A
    Transplantation; 1999 Feb; 67(4):534-8. PubMed ID: 10071023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ACE gene polymorphism correlation (I/D) with the ventricular function in patients with ischemic and idiopathic dilated cardiomyopathy].
    Avila-Vanzzini N; Espínola-Zavaleta N; Masso-Rojas F; Varela-López E; Casanova-Garcés JM; Kury-Alfaro J; Herrera-Bello H
    Rev Invest Clin; 2006; 58(1):39-46. PubMed ID: 16789598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the plasma angiotensin II levels and the risk of chronic heart failure].
    Huang WY; Sun M; Zhou HY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):198-200. PubMed ID: 16145913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between ACE gene polymorphism and ischemic chronic heart failure in Turkish population.
    Akbulut T; Bilsel T; Terzi S; Ciloglu F; Unal Dayi S; Sayar N; Peker I; Yesilcimen K
    Eur J Med Res; 2003 Jun; 8(6):247-53. PubMed ID: 12911874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.